Business Context and Reporting Period
Company: Alterity Therapeutics Limited
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: Month of January 2021
Date Filed: January 28, 2021
Principal Executive Office: Level 3, 460 Bourke Street, Melbourne, VIC 3000, Australia
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. The document serves as a cover sheet incorporating other reports by reference.
Material Changes
No material changes to financial performance or operations are detailed within the text of this specific Form 6-K. The filing references the incorporation of "Appendix 4C and Quarterly Cash Flow Report" into the document, but the content of those appendices is not included in the provided text.
Guidance, Outlook, and Risks
The filing text does not contain management commentary, forward-looking guidance, risk factors, or details on contingencies. It primarily confirms the incorporation of this report into Registration Statements on Form S-8 (Files No. 333-251073, 333-248980, 333-228671) and Form F-3 (Files No. 333-249311, 333-231417, 333-250076).
Investor Verification Checklist
- Verify the contents of "Appendix 4C and Quarterly Cash Flow Report" referenced in Item 99.1, as the actual financial data is not present in this cover sheet.
- Review the referenced Registration Statements (Form S-8 and Form F-3) for details on equity offerings or securities registered.
- Confirm the company's status as a Foreign Private Issuer filing under Form 20-F.